Recent clinical trials in acute lymphocytic leukemia by the Cancer and Leukemia Group B. (Q34123870)

31 July 2017

1 reference

title

Recent clinical trials in acute lymphocytic leukemia by the Cancer and Leukemia Group B. (English)

1 reference

acute lymphocytic leukemia

31 July 2017

0 references

1 reference

1 reference

R A Larson

1

1 reference

PubMed ID

11147228

31 July 2017

language of work or name

1 reference

1 December 2000

1 reference

Hematology / Oncology Clinics of North America

31 July 2017

1 reference

31 July 2017

14

1 reference

31 July 2017

6

1 reference

31 July 2017

1367-79, x

1 reference

Comparative pharmacokinetic studies of three asparaginase preparations

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970191-X

7 January 2021

Preliminary experience with a new chemotherapy regimen for adults with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970191-X

7 January 2021

The effects of postinduction intensification treatment with cytarabine and daunorubicin in adult acute lymphocytic leukemia: a prospective randomized clinical trial by Cancer and Leukemia Group B

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970191-X

7 January 2021

Compound GW506U78 in refractory hematologic malignancies: relationship between cellular pharmacokinetics and clinical response

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970191-X

7 January 2021

Hypersensitivity reactions to L-asparaginase do not impact on the remission duration of adults with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970191-X

7 January 2021

High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970191-X

7 January 2021

HiC-COM: a 2-month intensive chemotherapy regimen for children with stage III and IV Burkitt's lymphoma and B-cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970191-X

7 January 2021

Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970191-X

7 January 2021

10.1016/S0889-8588(05)70191-X

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11147228